Levofloxacin inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 8, 2012, Pages 4052-4061

  Yamaya, Mutsuo ^a   Nishimura, Hidekazu ^b   Hatachi, Yukimasa ^c   Yasuda, Hiroyasu ^d   Deng, Xue ^d   Sasaki, Takahiko ^e   Mizuta, Katsumi ^f   Kubo, Hiroshi ^a   Nagatomi, Ryoichi ^e  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SENDAI CITY MEDICAL CENTER   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

^e TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f YAMAGATA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LEVOFLOXACIN; PROTEIN P50; SYNAPTOTAGMIN I; VIRUS RNA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; PREMEDICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHINOVIRUS INFECTION; SUPERNATANT; TRACHEA MUCOSA;

ANTI-BACTERIAL AGENTS; CELLS, CULTURED; CYTOKINES; EPITHELIAL CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; NF-KAPPA B; OFLOXACIN; PICORNAVIRIDAE INFECTIONS; RECEPTORS, VIRUS; RESPIRATORY MUCOSA; RHINOVIRUS; RNA, VIRAL; TRACHEA;

EID: 84864387273     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00259-12     Document Type: Article

References (48)

1. Akira S, Hirano T, Taga T, Kishimoto T. 1990. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J. 4:2860-2867. (Pubitemid 120012532)
2. Asada M, et al. 2012. L-Carbocisteine inhibits respiratory syncytial virus infection in human tracheal epithelial cells. Respir. Physiol. Neurobiol. 180:112-118.
3. Asada M, et al. 2009. Macrolide antibiotics inhibit respiratory syncytial virus infection in human airway epithelial cells. Antiviral Res. 83:191-200.
4. Blasi F. 2004. Atypical pathogens and respiratory tract infections. Eur. Respir. J. 24:171-181. (Pubitemid 39029084)
5. Blau H, Klein K, Shalit I, Halperin D, Fabian I. 2007. Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-κB activation in a cystic fibrosis epithelial cell line. Am. J. Physiol. 292:L343-L352. (Pubitemid 46103459)
6. Casasnovas JM, Springer TA. 1994. Pathway of rhinovirus disruption by soluble intercellular adhesion molecule 1 (ICAM-1): an intermediate in which ICAM-1 is bound and RNA is released. J. Virol. 68:5882-5889.
7. Chodosh S, et al. 1998. Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. Clin. Infect. Dis. 27:730-738. (Pubitemid 29244326)
8. Condit RC. 2006. Principles of virology, p 25-57. In Knipe DM, et al (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
9. de la Campa AG, Garcia E, Fenoll A, Munoz R. 1997. Molecular bases of three characteristic phenotypes of pneumococcus: optochin-sensitivity, coumarin-sensitivity, and quinolone-resistance. Microb. Drug Resist. 3:177-193.
10. Gotfried MH, Danziger LH, Rodvold KA. 2001. Steady-state plasma and intrapulmonary concentrations of levofloxacin and ciprofloxacin in healthy adult subjects. Chest 119:1114-1122. (Pubitemid 32679439)
11. Greve JM, et al. 1989. The major human rhinovirus receptor is ICAM-1. Cell 56:839-847. (Pubitemid 19082519)
12. Hofer F, et al. 1994. Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc. Natl. Acad. Sci. U. S. A. 91:1839-1842. (Pubitemid 24080301)
13. Khan AA, Slifer TR, Remington JS. 1998. Effect of trovafloxacin on production of cytokines by human monocytes. Antimicrob. Agents Chemother. 42:1713-1717. (Pubitemid 28311567)
14. Kitazawa T, et al. 2007. Biphasic regulation of levofloxacin on lipopoly-saccharide-induced IL-1β production. Life Sci. 80:1572-1577. (Pubitemid 46412355)
15. Lachowicz-Scroggins ME, Boushey HA, Finkbeiner WE, Widdicombe JH. 2010. Interleukin-13-induced mucous metaplasia increases susceptibility of human airway epithelium to rhinovirus infection. Am. J. Respir. Cell Mol. Biol. 43:652-661.
16. Marshansky V, Vinay P. 1996. Proton gradient formation in early endosomes from proximal tubes. Biochim. Biophys. Acta 1284:171-180. (Pubitemid 26356151)
17. Mellman I, Fuchs R, Helenius A. 1986. Acidification of the endocytic and exocytic pathways. Annu. Rev. Biochem. 55:663-700. (Pubitemid 16070784)
18. Mizuta K, et al. 2010. Phylogenetic and cluster analysis of human rhinovirus species A (HRV-A) isolated from children with acute respiratory infections in Yamagata, Japan. Virus Res. 147:265-274.
19. Mori S, et al. 2010. Ciprofloxacin inhibits advanced glycation end products-induced adhesion molecule expression on human monocytes. Br. J. Pharmacol. 161:229-240.
20. + exchanger in a late endosomal compartment of yeast. Implications for vacuole biogenesis. J. Biol. Chem. 273:21054-21060.
21. Nolan T, Hands RE, Bustin SA. 2006. Quantification of mRNA using real-time RT-PCR. Nat. Protoc. 1:1559-1582.
22. Numazaki Y, et al. 1987. A microplate methods for isolation of viruses from infants and children with acute respiratory infections. Microbiol. Immunol. 31:1085-1095. (Pubitemid 18019293)
23. Nwariaku FE, McIntyre KL, Sikes PJ, Mileski WJ. 1997. The effect of antimicrobial agents on the induction of tumour necrosis factor by alveolar macrophages in vitro in response to endotoxin. J. Antimicrob. Chemother. 39:265-267. (Pubitemid 27116425)
24. Papi A, Johnston SL. 1999. Respiratory epithelial cell expression of vascular cell adhesion molecule-1 and its up-regulation by rhinovirus infection via NF-κB and GATA transcription factors. J. Biol. Chem. 274:30041-30051.
25. Pérez L, Carrasco L. 1993. Entry of poliovirus into cells does not require a low-pH step. J. Virol. 67:4543-4548. (Pubitemid 23215932)
26. Prchla E, Kuechler E, Blaas D, Fuchs R. 1994. Uncoating of human rhinovirus serotype 2 from late endosomes. J. Virol. 68:3713-3723. (Pubitemid 24177396)
27. Riise GC, Larsson S, Lofdahl CG, Andersson BA. 1994. Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis. Eur. Respir. J. 7:1673-1677. (Pubitemid 24294255)
28. Ruiz-Gonzalez A, et al. 2007. Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease. Respirology 12:117-121. (Pubitemid 44968210)
29. Sasaki T, et al. 2005. The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells. Eur. J. Pharmacol. 509:201-210. (Pubitemid 40279079)
30. Seemungal T, Harper-Owen R, Bhowmik A, Jeffries DJ, Wedzicha JA. 2000. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur. Respir. J. 16:677-683.
31. Sharma BN, Li R, Bernhoff E, Gutteberg TJ, Rinaldo CH. 2011. Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells. Antiviral Res. 92:115-123.
32. Shimoda K, Kato M. 1999. Apoptotic photoreceptor cell death induced by quinolone phototoxicity in mice. Toxicol. Lett. 105:9-15. (Pubitemid 29090342)
33. Subauste MC, Jacoby DB, Richards SM, Proud D. 1995. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J. Clin. Invest. 96:549-557.
34. Suzuki T, et al. 2001. Type 2 rhinovirus infection of cultured human tracheal epithelial cells: role of low density lipoprotein receptor. Am. J. Physiol. 280:L409-L420.
35. Suzuki T, et al. 2001. Bafilomycin A1 inhibits rhinovirus infection in human airway epithelium: effects on endosome and ICAM-1. Am. J. Physiol. 280:L1115-L1127.
36. Suzuki T, et al. 2002. Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells. Am. J. Respir. Crit. Care Med. 165:1113-1118. (Pubitemid 34415820)
37. Suzuki T, et al. 2000. Effects of dexamethasone on rhinovirus infection in cultured human tracheal epithelial cells. Am. J. Physiol. 278:L560-L571. (Pubitemid 30152514)
38. Terajima M, et al. 1997. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1β. Am. J. Physiol. 273:L749-L759.
39. Tomassini JE, et al. 1989. cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. U. S. A. 86:4907-4911. (Pubitemid 19182207)
40. Tsivkovskii R, et al. 2011. Levofloxacin reduces inflammatory cytokine levels in human bronchial epithelia cells: implications for aerosol MP-376 (levofloxacin solution for inhalation) treatment of chronic pulmonary infections. FEMS Immunol. Med. Microbiol. 61:141-146.
41. Turner RB, Couch RB. 2006. Rhinoviruses, p 895-909. In Knipe DM, et al (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
42. Wilson R, et al. 2004. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. Chest 125:953-964. (Pubitemid 38367286)
43. Yamaya M, et al. 2011. Procaterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. Eur. J. Pharmacol. 650:431-444.
44. Yamaya M, et al. 2010. Inhibitory effects of carbocisteine on type A seasonal influenza virus infection in human airway epithelial cells. Am. J. Physiol. 299:L160-L168.
45. Yamaya M, et al. 2010. Clarithromycin inhibits type A seasonal influenza virus infection in human airway epithelial cells. J. Pharmacol. Exp. Ther. 333:81-90.
46. Yoshimura T, et al. 1996. Immunomodulatory action of levofloxacin on cytokine production by human peripheral blood mononuclear cells. Chemotherapy 42:459-464. (Pubitemid 26379935)
47. Zhang J, et al. 2010. Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections. J. Clin. Pharmacol. 50:922-928.
48. Zhu Z, et al. 1996. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor κB-dependent transcriptional activation. J. Clin. Invest. 97:421-430.